<ѻý>Evidence of Safety, Efficacy for Salvaged Blood Irradiators Lacking, FDA Staff Sayѻý> Devices are aimed at preventing metastasis during surgery Nov 03, 2023
<ѻý>New Option Approved for Erosive Esophagitisѻý> Vonoprazan lands indication for healing and maintenance across all grades of condition Nov 02, 2023
<ѻý>FDA's Revolving Door; 2.4 Million Excess Deaths; Can Anorexia Be 'Terminal'?ѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 02, 2023
<ѻý>Stelara Biosimilar OK'd With Interchangeabilityѻý> But patent settlement may keep new product off market until 2025 Nov 01, 2023
<ѻý>Potential Cure for Sickle Cell Clears Hurdle for Approvalѻý> FDA advisors suggest the benefits of gene therapy outweigh risks of off-target editing Oct 31, 2023
<ѻý>FDA Outlines Rules for Telling Clinicians About Unapproved Uses of Drugs, Devicesѻý> Draft guidance explains what doesn't qualify as "scientifically sound" information Oct 31, 2023
<ѻý>FDA Reviewers Question Safety of Sickle Cell Gene Therapyѻý> Efficacy results "strongly positive," but unintended off-target effects a question Oct 30, 2023
<ѻý>FDA OKs First Drug for Nasopharyngeal Carcinomaѻý> Toripalimab approved in combination with first-line chemo, and as monotherapy after progression Oct 30, 2023
<ѻý>What if Trial Participants Knew Their Contributions Were for Naught?ѻý> A call for enforcing trial reporting requirements Oct 28, 2023
<ѻý>Novel Drug OK'd for Ulcerative Colitisѻý> First agent to target p19 subunit of IL-23 Oct 27, 2023
<ѻý>Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDSѻý> News, features, and commentary about cancer-related issues Oct 27, 2023
<ѻý>Novel Corticosteroid Approved for Rare Diseaseѻý> Vamorolone gets a nod from FDA for Duchenne muscular dystrophy Oct 27, 2023
<ѻý>Probiotics for Preterm Infants Could Pose Serious Danger, FDA Warnsѻý> Abbott, Infinant Health sent warning letters about their products Oct 26, 2023
<ѻý>IG Live October 23: Life in the Fast Lane With FDA's Accelerated Approvalsѻý> Experts share their perspectives on the increasingly controversial FDA pathway Oct 19, 2023
<ѻý>Eye Drops for Presbyopia Win FDA Approvalѻý> Pilocarpine hydrochloride solution improved distance-corrected vision in two phase III trials Oct 18, 2023
<ѻý>FDA Approves First Phosphate Absorption Inhibitor for CKDѻý> Tenapanor indicated for adults on dialysis who fail on phosphate binders Oct 18, 2023
<ѻý>Pembrolizumab Wins FDA Approval in Operable Lung Cancerѻý> Checkpoint inhibitor demonstrated significant survival improvement in perioperative setting Oct 17, 2023
<ѻý>Suzanne Somers Dies; FDA Plans to Ban Hair Relaxers; Health Worker Minimum Wageѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 16, 2023
<ѻý>New Oral Drug Approved for Ulcerative Colitis in Adultsѻý> S1P receptor modulator etrasimod indicated for moderately to severely active disease Oct 13, 2023
<ѻý>FDA Warns That Umbilical Cord Injection Is a Drugѻý> Company owner also has a stem cell clinic in Panama claiming to treat various conditions Oct 12, 2023
<ѻý>Combination Therapy Wins FDA Approval for BRAF-Mutated NSCLCѻý> Encorafenib plus binimetinib led to 75% ORR in untreated patients, 59% in treated patients Oct 12, 2023
<ѻý>FDA Warns on Compounded Ketamine for Psych Disordersѻý> The agency emphasized the drug is not approved for any psychiatric disorder Oct 12, 2023
<ѻý>FDA Turns Down ATTR Cardiomyopathy Drugѻý> Decision cites insufficient evidence of clinical meaningfulness Oct 09, 2023
<ѻý>Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panelѻý> But agency doesn't plan to immediately push for KRAS inhibitor's withdrawal Oct 05, 2023
<ѻý>FDA Panel Endorses DFMO for Kids' High-Risk Neuroblastoma in Remissionѻý> Large improvement in event-free survival, but questions linger about sources of data Oct 04, 2023
<ѻý>Drugmaker Plans to Pull Lung Cancer Therapy From the Marketѻý> Randomized trial of mobocertinib (Exkivity) failed to confirm benefit in rare tumor type Oct 04, 2023
<ѻý>FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLCѻý> Reviewers see potentially tiny PFS benefit with sotorasib, raise concerns over "systemic bias" Oct 04, 2023
<ѻý>Novavax's Updated COVID Shot Authorized by FDAѻý> Protein-based vaccine is refreshed with 2023-2024 formula targeting XBB strain Oct 03, 2023
<ѻý>FDA Advisors to Consider DFMO Maintenance for High-Risk Neuroblastoma in Kidsѻý> Lack of options for relapsed disease versus uncertainty about supporting data Oct 03, 2023
<ѻý>A Framework to Communicate With Pregnant Patients About the RSV Vaccineѻý> A values-based decision-making framework is key Oct 03, 2023
<ѻý>FDA Greenlights Test for Cancer-Predisposing Genetic Mutationsѻý> First-of-its-kind DNA test achieved 99% accuracy for variants in dozens of genes Oct 03, 2023
<ѻý>FDA OKs Another Injectable for Rare Kidney Disorderѻý> Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
<ѻý>Lab Tests That Escape FDA Oversight May Come Under Agency Reviewѻý> Agency proposes tighter oversight of laboratory developed tests Sep 29, 2023
<ѻý>New Option OK'd for Pompe Diseaseѻý> FDA approves two-component therapy for patients not improving on enzyme replacement therapy Sep 29, 2023
<ѻý>FDA Relents, Approves Novel Antidepressant After Many Rejectionsѻý> Gepirone extended-release approved after nearly 2 decades of trying Sep 28, 2023
<ѻý>FDA Adds Intestinal Blockage Reports to Ozempic Labelingѻý> Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<ѻý>FDA Panel Overwhelmingly Rejects ALS Cell Therapyѻý> Echoing concerns from agency reviewers, advisors can't find evidence of efficacy Sep 28, 2023
<ѻý>With Shutdown Likely, Policy Experts Weigh Health Risksѻý> Food safety, innovation, and community health centers all could see trickle-down effects Sep 28, 2023
<ѻý>FDA Displeased With Companies Purposely Adding Sesame to More Foodsѻý> Agency issues updated guidance for limiting cross-contamination in wake of FASTER act Sep 27, 2023
<ѻý>Mydriasis-Reversing Eye Drops Win FDA Approvalѻý> Pupil diameter normalized significantly faster with phentolamine solution in phase III trials Sep 27, 2023